share_log

Premier Health Reports 2023 Fourth Quarter Results

Premier Health Reports 2023 Fourth Quarter Results

卓越健康報告2023年第四季度業績
GlobeNewswire ·  2023/12/13 07:00

MONTRÉAL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the "Corporation"), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its financial year ended September 30, 2023.

蒙特利爾,2023年12月12日(GLOBE NEWSWIRE)——加拿大領先的健康科技公司Premier Health of America Inc.(多倫多證券交易所股票代碼:PHA)(以下簡稱 “公司”)宣佈已提交截至2023年9月30日的財政年度未經審計的季度合併財務報表和MD&A。

2023 Highlights
(in thousands of Canadian dollars) Sept 30, 2023
(3 months)
Sept 30, 2022
(3 months)
Sept 30, 2023
(12 months)
Sept 30, 2022
(12 months)
Revenues 23,405 22,087 90,390 80,507
Gross margin 6,036 5,851 23,345 20,084
Gross margin as a % of revenues 25.8% 26.5% 25.8% 24.9%
Adjusted EBITDA (1) 2,073 2,222 8,227 5,760
Net Loss (1,933) (37) (1,703) (112)
2023 年亮點
(以千加元計) 2023年9月30日
(3 個月)
2022年9月30日
(3 個月)
2023年9月30日
(12 個月)
2022年9月30日
(12 個月)
收入 23,405 22,087 90,390 80,507
毛利率 6,036 5,851 23,345 20,084
毛利率佔收入的百分比 25.8% 26.5% 25.8% 24.9%
調整後 EBITDA (1) 2,073 2,222 8,227 5,760
淨虧損 (1,933) (37) (1,703) (112)

(1) See the Corporation's MD&A for details on this non-Gaap measure.

(1) 有關這項非公認會計准則指標的詳細信息,請參閱公司的MD&A。

Summary

摘要

  • Gross margin for the quarter was 25.8%, in-line our long-term target of 25%.
  • Adjusted EBITDA for the quarter was $2.1M ($2.2M for the same period in 2022). For the twelve-month period, Adjusted EBITDA increased by $2.5M or 43%.
  • Net Loss for the quarter was $1.9M (nil for the same period in 2022).
  • 該季度的毛利率爲25.8%,符合我們25%的長期目標。
  • 本季度調整後的息稅折舊攤銷前利潤爲210萬美元(2022年同期爲220萬美元)。在十二個月期間,調整後的息稅折舊攤銷前利潤增加了250萬美元,增長了43%。
  • 該季度的淨虧損爲190萬美元(2022年同期爲零)。

During the fourth quarter of 2023, PHA suffered a slight decrease in Adjusted EBITDA when compared to last year. This is mainly due to acquisition costs related to the recently closed acquisition of Solutions Staffing Inc. in British Columbia, as well as the issuance of Deferred Share Units under the standard program for its directors. This quarter was generally in line with management's expectations, although a goodwill impairment loss was recorded against the Code Bleu agency. Such impairment follows the adoption of Bill 10 in Quebec, more information can be found in the Company's annual financial statements available on sedarplus.ca.

在2023年第四季度,PHA調整後的息稅折舊攤銷前利潤與去年相比略有下降。這主要是由於與最近完成的對不列顛哥倫比亞省Solutions Staffing Inc.的收購以及根據標準計劃爲其董事發行遞延股份單位相關的收購成本。儘管Code Bleu機構出現了商譽減值虧損,但本季度總體上符合管理層的預期。此類減值是在魁北克通過第10號法案之後發生的,更多信息可以在sedarplus.ca上提供的公司年度財務報表中找到。

"We are pleased by the performance of CHCA, and very excited of welcoming Solutions Staffing into our group. The timing of our expansion outside of Quebec was perfect, and this will be of great benefit to the group as we navigate through the regulatory changes from Quebec's Bill 10, effective since October 2023. Our eyes remain open to consolidate more assets in Ontario and the rest of Canada, and we feel there are still good opportunities available," said Martin Legault, CEO of Premier Health. "The Quebec market is evolving, and we still believe agencies will play a role in the future state of its healthcare system. We need to be smart, adapt, and use our scale to be competitive."

“我們對CHCA的表現感到滿意,也很高興歡迎Solutions Staffing加入我們的團隊。我們在魁北克以外地區擴張的時機是完美的,這將使集團受益匪淺,因爲我們正在研究自2023年10月起生效的魁北克第10號法案的監管變化。我們仍然睜大眼睛整合安大略省和加拿大其他地區的更多資產,我們認爲仍有很好的機會可用,”Premier Health首席執行官馬丁·勒戈特說。 “魁北克市場正在發展,我們仍然相信各機構將在其醫療保健系統的未來狀態中發揮作用。我們需要變得聰明、適應並運用我們的規模來提高競爭力。”

Business Highlights and recent developments

業務亮點和最新發展

  • The Corporation provided 209,421 hours of service during the quarter (217,100 hours in Q3 of 2023).
  • Acquisition of Solutions Staffing (British Columbia, Canada), completed on November 9th, 2023.
  • $50M acquisition financing and refinancing of our revolving credit and a term loan completed on the same day.
  • Renewed contract with Indigenous Services Canada for CHCA – the contract has a term of 4 years plus 4 one-year extensions.
  • New contracts with the Cree Board of Health and Social Services of James Bay.
  • Extension of the main procurement contract in Quebec until June of 2024.
  • Official deployment of our LiPHe platform in our Code Bleu subsidiary. The next deployment will be at CHCA and is targeted for Q3 of 2024.
  • 該公司在本季度提供了209,421小時的服務(2023年第三季度爲217,100小時)。
  • 對 Solutions Faffing(加拿大不列顛哥倫比亞省)的收購,於 11 月 9 日完成第四,2023。
  • 我們的循環信貸和定期貸款的5000萬美元收購融資和再融資於同一天完成。
  • 與加拿大土著服務部續訂了CHCA的合同——該合同的期限爲4年,外加4年的延期。
  • 與詹姆斯灣克里衛生與社會服務委員會簽訂的新合同。
  • 將魁北克的主要採購合同延長至2024年6月。
  • 在我們的 Code Bleu 子公司正式部署我們的 LipHe 平台。下一次部署將在CHCA進行,目標是2024年第三季度。

Solutions Staffing Inc.

解決方案人員配備公司

This acquisition is a major milestone in terms of geographical diversification of PHA. It also expands our base in the travel nurse segment, which, because of longer term assignments, is simpler to manage. Based on its 2022 fiscal year, SSI had revenues of $74.0M and an EBITDA of $6.7M. On a proforma basis, PHA's revenue base outside Quebec will represent over 60% of total revenues.

就PHA地域多元化而言,此次收購是一個重要的里程碑。它還擴大了我們在旅行護士領域的基礎,由於任務期限較長,因此更易於管理。根據其2022財年,SSI的收入爲7,400萬美元,息稅折舊攤銷前利潤爲670萬美元。按形式計算,PHA在魁北克以外的收入基礎將佔總收入的60%以上。

About Premier Health

關於卓越健康

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary LiPHe platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.

Premier Health 是一家領先的加拿大醫療科技公司,爲政府、企業和個人提供全面的外包服務解決方案,以滿足醫療保健需求。Premier Health 使用其專有的LipHe平台引領醫療服務行業的數字化轉型,爲患者提供更快、更便宜、更容易獲得的護理服務。

Non-GAAP Measures

非公認會計准則指標

Earnings before interest, taxes, depreciation, and amortization ("EBITDA"), is calculated as the net profit (loss), before non-recurring items excluding acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization, and depreciation), interest expense, net of interest income and income tax expense. More detail can be found in PHA's Management Discussion and Analysis.

扣除利息、稅項、折舊和攤銷前的收益(“EBITDA”)按扣除非經常性項目前的淨利潤(虧損)計算,不包括收購和交易成本、非現金支出(包括資產處置損失、減值、攤銷和折舊)、利息支出,扣除利息收入和所得稅支出。更多細節可以在PHA的管理討論與分析中找到。

For Further Information Please Contact:

欲了解更多信息,請聯繫:

Mr. Guy Daoust
Chief Financial Officer
Premier Health of America Inc.
gdaoust@premierhealth.ca / 1 800 231 9916

蓋伊·達烏斯特先生
首席財務官
美國頂級健康公司
gdaoust@premierhealth.ca/1 800 231 9916

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

關於前瞻性信息的警示性聲明:

This press release contains forward-looking information within the meaning of applicable securities legislation which reflects the current plans and expectations of the Corporation with respect to future events and financial performance. All statements other than statements of historical or current facts may be forward-looking information. Forward-looking information includes statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as 'believes', 'continues', 'expects', 'projects', 'anticipates', 'plans', 'estimates', 'seeks', 'intends', 'targets', 'forecasts', or negative or grammatical versions thereof and other similar expressions, or future or conditional verbs such as 'may', 'will', 'should', 'would' and 'could'. Forward-looking information in this press release includes, but is not limited to, statements with respect to the execution of the Corporation's growth strategy. Forward-looking information is based on management's plans, estimates, projections, beliefs and opinions as at the date of this release, and the assumptions related to those plans, estimates, projections, beliefs and opinions may change; therefore, they are presented for the purpose of assisting the Corporation's security holders in understanding management's views at such time regarding those future outcomes and may not be appropriate for other purposes. Although the forward-looking information contained in this release is based on assumptions which the Corporation believes are reasonable, there can be no assurance that actual results will be consistent with such forward-looking information. The forward-looking information in this release relate only to events or information as of the date on which the statements are made and, except as specifically required by applicable securities laws, the Corporation undertakes no obligation to update or revise publicly any forward-looking information, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. There can be no assurance that the forward-looking information will prove to be accurate. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at

本新聞稿包含適用的證券立法所指的前瞻性信息,這些信息反映了公司對未來事件和財務業績的當前計劃和預期。除歷史或當前事實陳述以外的所有陳述都可能是前瞻性信息。前瞻性信息包括本質上具有預測性、取決於或提及未來事件或條件的陳述,或者包括諸如 “相信”、“繼續”、“期望”、“預期”、“計劃”、“估計”、“尋求”、“打算”、“目標”、“預測” 或其負面或語法版本以及其他類似表達方式,或未來或條件動詞,例如 “可能” '、' 將 '、' 應該 '、' 會 '和' 可以 '。本新聞稿中的前瞻性信息包括但不限於與公司增長戰略執行有關的聲明。前瞻性信息基於管理層截至本新聞稿發佈之日的計劃、估計、預測、信念和觀點,與這些計劃、估計、預測、信念和觀點相關的假設可能會發生變化;因此,提供前瞻性信息是爲了幫助公司的證券持有人了解管理層當時對這些未來結果的看法,可能不適合用於其他目的。儘管本新聞稿中包含的前瞻性信息基於公司認爲合理的假設,但無法保證實際業績會與此類前瞻性信息一致。本新聞稿中的前瞻性信息僅涉及截至陳述發表之日的事件或信息,除非適用的證券法有明確要求,否則公司沒有義務在陳述發表之日之後公開更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因,也沒有義務公開更新或修改任何前瞻性信息,也沒有義務反映意外事件的發生。無法保證前瞻性信息會被證明是準確的。這些陳述不應被視爲對未來業績或結果的保證。此類陳述涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致實際結果、業績或成就與此類陳述所暗示的結果存在重大差異。除非法律要求,否則公司不負責更新或修改前瞻性信息以反映新的事件或情況。公司向加拿大證券監管機構提交的文件中對這些因素和其他因素進行了更全面的討論,網址爲


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論